Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy

被引:2
作者
Tanaka, Tomohiro [1 ,2 ]
Goto, Yasushi [1 ]
Horie, Masafumi [3 ]
Masuda, Ken [1 ]
Shinno, Yuki [1 ]
Matsumoto, Yuji [1 ]
Okuma, Yusuke [1 ]
Yoshida, Tatsuya [1 ]
Horinouchi, Hidehito [1 ]
Motoi, Noriko [4 ]
Yatabe, Yasushi [5 ,6 ]
Watanabe, Shunichi [7 ]
Yamamoto, Noboru [1 ]
Ohe, Yuichiro [1 ]
机构
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan
[2] Niigata Univ Med & Dent Hosp, Dept Resp Med & Infect Dis, Niigata 9518510, Japan
[3] Kanazawa Univ, Dept Mol & Cellular Pathol, Kanazawa 9208640, Japan
[4] Saitama Canc Ctr, Dept Pathol, Saitama 3620806, Japan
[5] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan
[6] Natl Canc Ctr, Clin Lab, Tokyo 1040045, Japan
[7] Natl Canc Ctr, Dept Thorac Surg, Tokyo 1040045, Japan
关键词
thymoma; whole-exome sequencing; pemetrexed; copy number variations; exceptional response; THYMIC EPITHELIAL TUMORS; COPY NUMBER VARIATION; MISSENSE MUTATION; EXTRAORDINARY RESPONSE; CANCER; CHROMOSOME-6; THERAPY; ADENOCARCINOMA; ABERRATIONS; REGIMEN;
D O I
10.3390/cancers15164018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Pemetrexed, a multi-target anti-folate agent, is the treatment choice for advanced or metastatic thymoma at the second or later line setting. Thymoma patients occasionally show an exceptionally durable and deep response to pemetrexed treatment. Recent studies using next-generation sequencing have identified some genomic aberrations in such patients, but the mechanism underlying their sensitivity to pemetrexed remains unclear. This study explores certain somatic single-nucleotide variants or copy number variations (CNVs) in exceptional responders to pemetrexed treatment. To elucidate any genomic changes, we performed whole-exome sequencing in patients with advanced thymomas treated with pemetrexed. We found no differences between the exceptional and typical responders, but the highest number of whole arm gain or the loss of chromosomal CNVs was observed in an exceptional responder to pemetrexed. Our study provides additional genomic findings on thymomas and chemosensitivity. Background: Pemetrexed is used for the chemotherapy of advanced thymoma. Exceptional responses of thymoma to pemetrexed treatment are not frequently observed. The underlying genetic mechanism of the exceptional responses remains unclear. We used whole-exome sequencing to explore the specific genomic aberrations that lead to an extreme and durable response. Methods: Whole-exome sequencing using NovaSeq6000 (150 bp paired-end sequencing) was performed on nine formalin-fixed paraffin-embedded tissues from patients with advanced thymomas treated with pemetrexed (two exceptional responders and seven typical responders). Results: We identified 284 somatic single-nucleotide variants (SNVs; 272 missense, 8 missense/splice-site, 3 stop-gain, and 1 stop-gain/splice-site), 34 insertions and deletions (Indels; 33 frameshift and one splice region), and 21 copy number variations (CNVs; 15 gains and six losses). No difference in the number of SNVs variants and distribution of deleterious Indels was observed between the exceptional and typical responders. Interestingly, arm-level chromosomal CNVs (15 gains and six losses) were detected in four patients, including an exceptional responder. The highest number of arm-level CNVs was observed in an exceptional responder. Conclusion: Exceptional responders to pemetrexed for metastatic thymomas may be characterized by arm-level CNVs. Further, whole-genome and RNA sequencing studies should be performed.
引用
收藏
页数:16
相关论文
共 67 条
[21]   Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing [J].
Gray, Heidi J. ;
Chatterjee, Payel ;
Rosati, Rachele ;
Appleyard, Lauren R. ;
Durenberger, Grace J. ;
Diaz, Robert L. ;
Swan, Hallie A. ;
Peretti, Danielle ;
Pollastro, Maddy ;
Ainge, Trevor ;
Kapeli, Katannya ;
Pereira, Shalini ;
Margossian, Astrid L. ;
Banda, Kalyan ;
Goff, Barbara A. ;
Swisher, Elizabeth M. ;
Bernard, Brady ;
Kemp, Christopher J. ;
Grandori, Carla .
NPJ PRECISION ONCOLOGY, 2023, 7 (01)
[22]   LZTR1: Genotype Expansion in Noonan Syndrome [J].
Guemes, Maria ;
Martin-Rivada, Alvaro ;
Ortiz-Cabrera, Neimar Valentina ;
Martos-Moreno, Gabriel Angel ;
Pozo-Roman, Jesus ;
Argente, Jesus .
HORMONE RESEARCH IN PAEDIATRICS, 2020, 92 (04) :269-275
[23]   World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages [J].
Hattori, Natsuki ;
Hirose, Yuichi ;
Sasaki, Hikaru ;
Nakae, Shunsuke ;
Hayashi, Saeko ;
Ohba, Shigeo ;
Adachi, Kazuhide ;
Hayashi, Takuro ;
Nishiyama, Yuya ;
Hasegawa, Mitsuhiro ;
Abe, Masato .
CANCER SCIENCE, 2016, 107 (08) :1159-1164
[24]   Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma? [J].
Hirai, Fumihiko ;
Toyozawa, Ryo ;
Nosaki, Kaname ;
Seto, Takashi .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) :115-121
[25]   Chromosome 6 suffers frequent and multiple aberrations in thymoma [J].
Inoue, M ;
Marx, A ;
Zettl, A ;
Ströbel, P ;
Müller-Hermelink, HK ;
Starostik, P .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1507-1513
[26]   Investigation of the freely available easy-to-use software 'EZR' for medical statistics [J].
Kanda, Y. .
BONE MARROW TRANSPLANTATION, 2013, 48 (03) :452-458
[27]   VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing [J].
Koboldt, Daniel C. ;
Zhang, Qunyuan ;
Larson, David E. ;
Shen, Dong ;
McLellan, Michael D. ;
Lin, Ling ;
Miller, Christopher A. ;
Mardis, Elaine R. ;
Ding, Li ;
Wilson, Richard K. .
GENOME RESEARCH, 2012, 22 (03) :568-576
[28]   Molecular profiling of primary uveal melanoma: results of a Polish cohort [J].
Kowalik, Artur ;
Karpinski, Pawel ;
Markiewicz, Anna ;
Orlowska-Heitzman, Jolanta ;
Romanowska-Dixon, Bozena ;
Donizy, Piotr ;
Hoang, Mai P. .
MELANOMA RESEARCH, 2023, 33 (02) :104-115
[29]  
Krejci J, 2011, CANCER GENOM PROTEOM, V8, P135
[30]   The mutation spectrum revealed by paired genome sequences from a lung cancer patient [J].
Lee, William ;
Jiang, Zhaoshi ;
Liu, Jinfeng ;
Haverty, Peter M. ;
Guan, Yinghui ;
Stinson, Jeremy ;
Yue, Peng ;
Zhang, Yan ;
Pant, Krishna P. ;
Bhatt, Deepali ;
Ha, Connie ;
Johnson, Stephanie ;
Kennemer, Michael I. ;
Mohan, Sankar ;
Nazarenko, Igor ;
Watanabe, Colin ;
Sparks, Andrew B. ;
Shames, David S. ;
Gentleman, Robert ;
de Sauvage, Frederic J. ;
Stern, Howard ;
Pandita, Ajay ;
Ballinger, Dennis G. ;
Drmanac, Radoje ;
Modrusan, Zora ;
Seshagiri, Somasekar ;
Zhang, Zemin .
NATURE, 2010, 465 (7297) :473-477